Duke Neurosurgery researchers have identified a driver of resistance to immunotherapies in deadly brain tumors, which could be targeted — allowing this type of drug to do its work.
While considered a single ethnic group, the differences found in the occurrence and outcomes of glioma brain tumor patients suggests important diversity.
The Preston Robert Tisch Brain Tumor Center kicked off Brain Tumor Awareness Month (May) on April 30 with their first full-scale Angels Among Us event since the pandemic began.
Nine-year brain cancer survivor Shelby Black talks about her experiences with Bobby's Coaches, Duke's peer support program for young adults with cancer.
Stacia Smart rolled in to Duke Medicine Circle on Oct. 8 to welcoming cheers. She had just cycled 1,100-mile in memory of her boyfriend Owen Strong who passed away from glioblastoma in Jan. 2020.
The V Foundation's Victory Ride to Cure Cancer was back as a LIVE cycling event and celebration, Aug. 28. Team DCI "virtual" and in-person riders raised more than $20K.
The Angels Among Us 5K & Walk of Hope will now run virtually from Sept. 25 through Oct. 10. Run, walk, bike, or crawl a 5K and/or 1-miler. Join an online Celebration of Hope.
The authors, including corresponding author Madan Kwatra, MD, report that osimertinib inhibits the constitutive activity of EGFRv III tyrosine kinase with high potency.
Substitute teacher and cancer survivor Tim McKenna, was teaching history at the Durham School of the Arts when a gas explosion ripped through downtown Durham.
Overall cancer mortality continues to decline. A special section on adults ages 20 to 49 shows higher cancer incidence and mortality for women than men.
While there have been many successes with newer chemotherapies, targeted therapies, and immunotherapies, many cancer types in the human population don...
Duke and UNC researchers receive CTSA Consortium Collaborative Pilot Award to develop a new way to study cancerFor doctors and patients, the fight aga...
David M. Ashley, PhD, was recently named director of The Preston Robert Tisch Brain Tumor Center. He succeeds Darell Bigner, MD, PhD, who became direc...
On Wednesday, Sept. 28, Matthias Gromeier, MD; Eric Thompson, MD; and Darell Bigner, MD, PhD; received a check for $208,408 from The Andrew McDonough ...
Every spring, come rain or come shine, patients, survivors, caregivers, loved ones, and Duke faculty and staff gather at the Angels Among Us 5K and Wa...
Behind every team photo and supportive hug at the annual Angels Among Us 5K and family fun run are stories of personal struggle and hope, love and new...
Co-leader of the Duke Cancer Institute Neuro-Oncology Research Program John Sampson, MD, PhD, has been elected to the Association of American Physicia...
More than 4,000 participants from across the U.S. came together on Saturday, April 29, to show support and raise funds to ensure ongoing brain cancer ...
Thousands of people from throughout the country laced up on Saturday, April 23, for the 23rd annual Angels Among Us 5K and Family Fun Walk. The event,...
More than 4,000 participants attended the 25th Annual Angels Among Us 5K on Saturday, April 28. Together, they raised a record $2.3 million to support...
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer — a strain of salmonel...
Marathon runner and brain cancer survivor Tom O’Donnell presents a check to Ellen Stainback, director of External Relations at the Preston Robert Tisc...
The V Foundation for Cancer Research has awarded David Ashley, MBBS, FRACP, PhD, a three-year $600,000 grant for his proposed research project “Poliov...
The recombinant poliovirus therapy developed at the Preston Robert Tisch Brain Tumor Center at Duke Health has been granted “breakthrough therapy desi...